Abstracts tagged "safety and steroids"

Abstract Number: 1546 • 2018 ACR/ARHP Annual Meeting
Efficacy and Safety of Corticosteroids in Rheumatoid Arthritis: Systematic Literature Review and Practical Recommendations
Raimon Sanmartí¹, Jesús Tornero Molina², Francisco Javier Narváez³, Alejandro Muñoz⁴, Elena Garmendia⁵, Ana M. Ortiz Garcia⁶, Miguel A. Abad⁷, Patricia Moya⁸, Maria Lourdes Mateo⁹, Delia Reina¹⁰, Juan Salvatierra Osorio¹¹, Sergio Rodriguez¹², Ana Rubial Escribano¹³, Natalia Palmou-Fontana¹⁴ and Jaime Calvo-Alén¹⁵, ¹Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, ²Rheumatology Unit, Hospital de Guadalajara, Guadalajara, Spain, ³Rheumatology Department, Hospital Universitario de Bellvitge, Idibell, Barcelona, Spain, ⁴Rheumatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain, ⁵Rheumatology, Hospital Universitario Cruces. Barakaldo. Spain, Barakaldo, Spain, ⁶Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, ⁷FEA Reumatología, Hospital Virgen del Puerto, Cáceres, Spain, ⁸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, ⁹Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, ¹⁰Rheumatology, Hospital Moises Broggi, Sant Joan Despí, Spain, ¹¹Complejo Hospitalario Universitario de Granada, Granada, Spain, ¹²Rheumatology, Hospital Universitario Virgen de Valme, Sevilla, Spain, ¹³Rheumatology, Hospital Alfredo Espinosa, Urduliz, Spain, ¹⁴Hospital Universitario Marqués de Valdecilla, IDIVAL. Universidad of Cantabria, Santander, Spain, ¹⁵Rheumatology Department, Hospital Universitario Araba. Vitoria-Gasteiz, Alava, Spain
Background/Purpose: Corticosteroids are effective in rheumatoid arthritis (RA) patients but their adverse events limit their use. The aim of this study was to: 1) To…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].